The aim of this study was to investigate the anti-obesity effects of DWP16001, a sodium-glucose cotransporter-2 (SGLT2 inhibitor), in naturally obese dogs. This evidence concerns the gene SLC5A2 and obesity due to melanocortin 4 receptor deficiency.